Safe Orthopaedics SA (ALSAF) - Cash Flow Conversion Efficiency

Latest as of June 2025: 0.098x

Based on the latest financial reports, Safe Orthopaedics SA (ALSAF) has a cash flow conversion efficiency ratio of 0.098x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-1.53 Million ≈ $-1.79 Million USD) by net assets (€-15.70 Million ≈ $-18.36 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Safe Orthopaedics SA - Cash Flow Conversion Efficiency Trend (2012–2024)

This chart illustrates how Safe Orthopaedics SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read ALSAF liabilities breakdown for a breakdown of total debt and financial obligations.

Safe Orthopaedics SA Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Safe Orthopaedics SA ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Block Energy PLC
LSE:BLOE
0.007x
Mosman Oil and Gas Ltd
LSE:MSMN
-0.118x
Konan Technology Inc.
KQ:402030
N/A
DSW Capital PLC
LSE:DSW
-0.032x
Cerinnov Group SA
PA:ALPCV
0.999x
LORDS CO. WORLDW. HOLD.
F:4XM
N/A
IMAC Holdings Inc
NASDAQ:BACK
0.228x
Zoo Digital Group Plc
LSE:ZOO
0.019x

Annual Cash Flow Conversion Efficiency for Safe Orthopaedics SA (2012–2024)

The table below shows the annual cash flow conversion efficiency of Safe Orthopaedics SA from 2012 to 2024. For the full company profile with market capitalisation and key ratios, see ALSAF market cap overview.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €-8.42 Million
≈ $-9.85 Million
€-3.27 Million
≈ $-3.82 Million
0.388x +6809.83%
2023-12-31 €-202.35 Million
≈ $-236.57 Million
€-1.14 Million
≈ $-1.33 Million
0.006x -99.87%
2022-12-31 €-1.28 Million
≈ $-1.50 Million
€-5.47 Million
≈ $-6.40 Million
4.277x +127.20%
2021-12-31 €398.00K
≈ $465.30K
€-6.26 Million
≈ $-7.32 Million
-15.726x +37.73%
2020-12-31 €237.00K
≈ $277.08K
€-5.99 Million
≈ $-7.00 Million
-25.253x -2243.74%
2019-12-31 €-4.28 Million
≈ $-5.00 Million
€-5.04 Million
≈ $-5.90 Million
1.178x +122.61%
2018-12-31 €1.19 Million
≈ $1.39 Million
€-6.21 Million
≈ $-7.27 Million
-5.210x -11.80%
2017-12-31 €1.06 Million
≈ $1.24 Million
€-4.93 Million
≈ $-5.76 Million
-4.660x +70.49%
2016-12-31 €367.00K
≈ $429.06K
€-5.80 Million
≈ $-6.78 Million
-15.793x -1137.00%
2015-12-31 €5.09 Million
≈ $5.95 Million
€-6.50 Million
≈ $-7.60 Million
-1.277x +37.81%
2014-12-31 €2.46 Million
≈ $2.88 Million
€-5.05 Million
≈ $-5.91 Million
-2.053x -111.11%
2013-12-31 €-194.00K
≈ $-226.81K
€-3.58 Million
≈ $-4.19 Million
18.479x +960.95%
2012-12-31 €1.17 Million
≈ $1.37 Million
€-2.51 Million
≈ $-2.93 Million
-2.146x --

About Safe Orthopaedics SA

PA:ALSAF France Medical Instruments & Supplies
Market Cap
$152.55K
€130.48K EUR
Market Cap Rank
#30902 Global
#592 in France
Share Price
€0.72
Change (1 day)
-1.37%
52-Week Range
€0.00 - €2.40
All Time High
€1000000.00
About

Safe Orthopaedics SA, a medical technology company, develops and markets ready-to-use implants and sterile instrumentation for spinal surgery in France. It offers SteriSpine PS, an all-round kit for open, mini open, and MIS surgeries, as well as percutaneous kit; SteriSpine VA, a product platform for ready to use Kyphoplasty and Cement systems; SteriSpine LC, a ready to use instrumentation for lu… Read more